Avinger (NASDAQ:AVGR) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR) in a report released on Wednesday morning. The firm issued a hold rating on the medical device company’s stock.

Separately, HC Wainwright reiterated a buy rating and issued a $5.00 price objective on shares of Avinger in a research note on Thursday, March 21st.

Avinger Stock Performance

NASDAQ:AVGR opened at $3.70 on Wednesday. The firm has a market cap of $5.87 million, a price-to-earnings ratio of -0.14 and a beta of 1.26. Avinger has a 52 week low of $2.50 and a 52 week high of $18.00. The firm has a 50-day moving average price of $3.42 and a two-hundred day moving average price of $3.33.

Avinger (NASDAQ:AVGR) last posted its quarterly earnings data on Wednesday, March 20th. The medical device company reported ($3.93) EPS for the quarter, missing the consensus estimate of $0.64 by ($4.57). The business had revenue of $1.91 million for the quarter, compared to analysts’ expectations of $2.52 million. As a group, sell-side analysts forecast that Avinger will post -2.08 earnings per share for the current year.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.